300 related articles for article (PubMed ID: 9440695)
1. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
[TBL] [Abstract][Full Text] [Related]
2. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
3. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.
Cheung KJ; Mitchell D; Lin P; Li G
Cancer Res; 2001 Jul; 61(13):4974-7. PubMed ID: 11431327
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
Garkavtsev I; Kazarov A; Gudkov A; Riabowol K
Nat Genet; 1996 Dec; 14(4):415-20. PubMed ID: 8944021
[TBL] [Abstract][Full Text] [Related]
6. Expression of the novel tumour suppressor p33(ING1)is independent of p53.
Cheung KJ; Bush JA; Jia W; Li G
Br J Cancer; 2000 Dec; 83(11):1468-72. PubMed ID: 11076655
[TBL] [Abstract][Full Text] [Related]
7. The tumour suppressor p33ING1 does not enhance camptothecin-induced cell death in melanoma cells.
Cheung KJ; Li G
Int J Oncol; 2002 Jun; 20(6):1319-22. PubMed ID: 12012016
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.
Shinoura N; Muramatsu Y; Nishimura M; Yoshida Y; Saito A; Yokoyama T; Furukawa T; Horii A; Hashimoto M; Asai A; Kirino T; Hamada H
Cancer Res; 1999 Nov; 59(21):5521-8. PubMed ID: 10554029
[TBL] [Abstract][Full Text] [Related]
9. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
10. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis.
Helbing CC; Veillette C; Riabowol K; Johnston RN; Garkavtsev I
Cancer Res; 1997 Apr; 57(7):1255-8. PubMed ID: 9102209
[TBL] [Abstract][Full Text] [Related]
11. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
12. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
13. The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells.
Cheung KJ; Li G
Int J Oncol; 2002 Dec; 21(6):1361-5. PubMed ID: 12429989
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of the p53 tumor suppressor pathway in head and neck cancer.
Hoque MO; Kawamata H; Nakashiro K; Omotehara F; Hino S; Uchida D; Harada K; Begum NM; Yoshida H; Sato M; Fujimori T
Int J Oncol; 2002 Jul; 21(1):119-26. PubMed ID: 12063558
[TBL] [Abstract][Full Text] [Related]
15. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2.
Leung KM; Po LS; Tsang FC; Siu WY; Lau A; Ho HT; Poon RY
Cancer Res; 2002 Sep; 62(17):4890-3. PubMed ID: 12208736
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor ING1: structure and function.
Cheung KJ; Li G
Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
20. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
